Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo

SIMPLE SUMMARY: There is a dire need for novel therapeutic interventions to treat osteosarcoma. Pyridazinone derivatives have proven some efficacy in several cancer models, but their effect on osteosarcoma is yet to be evaluated. Our goal was to synthesize and evaluate, both in vitro and in vivo, so...

Descripción completa

Detalles Bibliográficos
Autores principales: Moniot, Aurélie, Braux, Julien, Bour, Camille, Guillaume, Christine, Lamret, Fabien, Allart-Simon, Ingrid, Audonnet, Sandra, Renault, Sarah, Rédini, Francoise, Laronze-Cochard, Marie, Sapi, Janos, Gangloff, Sophie C., Gérard, Stéphane, Velard, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656549/
https://www.ncbi.nlm.nih.gov/pubmed/34885102
http://dx.doi.org/10.3390/cancers13235992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656549/
https://www.ncbi.nlm.nih.gov/pubmed/34885102
http://dx.doi.org/10.3390/cancers13235992

Ejemplares similares